F18, a Novel Small-Molecule Nonnucleoside Reverse Transcriptase Inhibitor, Inhibits HIV-1 Replication Using Distinct Binding Motifs as Demonstrated by Resistance Selection and Docking Analysis
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
F18, a Novel Small-Molecule Nonnucleoside Reverse Transcriptase Inhibitor, Inhibits HIV-1 Replication Using Distinct Binding Motifs as Demonstrated by Resistance Selection and Docking Analysis
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 56, Issue 1, Pages 341-351
Publisher
American Society for Microbiology
Online
2011-10-29
DOI
10.1128/aac.05537-11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Effect of Highly Active Antiretroviral Therapy on the Survival of HIV-Infected Children in a Resource-Deprived Setting: A Cohort Study
- (2011) Andrew Edmonds et al. PLOS MEDICINE
- Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials
- (2010) Christine Katlama et al. ANTIVIRAL THERAPY
- Retroviral reverse transcriptases
- (2010) Alon Herschhorn et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Highly Suppressing Wild-Type HIV-1 and Y181C Mutant HIV-1 Strains by 10-Chloromethyl-11-demethyl-12-oxo-calanolide A with Druggable Profile
- (2010) Hai Xue et al. JOURNAL OF MEDICINAL CHEMISTRY
- TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1
- (2009) H. Azijn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral Activity of MK-4965, a Novel Nonnucleoside Reverse Transcriptase Inhibitor
- (2009) M.-T. Lai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Etravirine: A second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV
- (2009) Daryl S. Schiller et al. CLINICAL THERAPEUTICS
- New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir
- (2009) Christine A Hughes et al. EXPERT OPINION ON PHARMACOTHERAPY
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Reduced morbidity and mortality in the first year after initiating highly active anti-retroviral therapy (HAART) among Ugandan adults
- (2009) George Miiro et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- HIV-1 at 25
- (2008) David D. Ho et al. CELL
- Prevalence of Drug-Resistant HIV-1 in Rural Areas of Hubei Province in the Peopleʼs Republic of China
- (2008) Minqi Luo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Chemical Library and Structure–Activity Relationships of 11-Demethyl-12-oxo Calanolide A Analogues as Anti-HIV-1 Agents
- (2008) Tao Ma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition
- (2008) Stefan G. Sarafianos et al. JOURNAL OF MOLECULAR BIOLOGY
- Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase
- (2008) Luis Menéndez-Arias VIRUS RESEARCH
- Chemical resolution of (±)-calanolide A, (±)-cordatolide A and their 11-demethyl analogues
- (2007) Tao Ma et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search